Through the PA-16-421 (R18) grant program, AHRQ addressed "patient safety and medication research by focusing on the safe usage of medications". This perspective centers on how medications move through the health care system and how this systemic process can be improved so that patients are not harmed, while health care delivery is improved. In addition, this program encouraged "the involvement of all members of the health care team, especially patients and families; nurses, pharmacists, technicians (pharmacy and medication administration technicians), health care administrators, risk managers, and physicians across all settings of care (including in the home)". Through this mechanism, AHRQ funded "investigative research demonstration projects that examine the effective implementation of processes, policies, and behaviors that support safe use of medication as well as its sustainment and dissemination."

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral and clinical research needs.

Through its Global Medical Grants program, pharmaceutical giant Pfizer supports independent initiatives (research, quality improvement, education) of the global healthcare community to improve patient outcomes in areas of unmet medical need that are aligned with its medical and/or scientific strategies. To that end, Pfizer has issued an RFP for its Managing the IBD Patient initiative. Through the RFP, grants of up to $250,000 will be awarded for the design of educational programs that reach nurses, nurse practitioners, and physician assistants who care for patients with irritable bowel disease. Pfizer will award up to four projects through this RFP.

This funding opportunity announcement (FOA) solicits research projects that seek to model the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in health, illness, recovery, and overall wellbeing. Both animal and human subjects research projects are welcome. Researchers proposing basic science experimental studies involving human participants should consider this FOAs companion for basic experimental studies with humans.

The purpose of this Funding Opportunity Announcement is to encourage grant applications that address the influence of patient activation on self-management of chronic conditions.

The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research that harnesses the wealth of advances in the fields of genomics and other omics (e.g., metabolomics, microbiomics, proteomics, transcriptomics, epigenomics, etc.) to incorporate these advances into translatable, personalized biobehavioral interventions for improved health outcomes.

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for support of innovative clinical, preclinical and non-clinical research to determine the potential of MDSCs as a target for host-directed therapeutics for tuberculosis in the context of HIV co-infection, and to better understand the role of host-induced immunosuppression in the progression of Mycobacterium tuberculosis pathogenesis.

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for support of innovative clinical, preclinical and non-clinical research to determine the potential of MDSCs as a target for host-directed therapeutics for tuberculosis in the context of HIV co-infection, and to better understand the role of host-induced immunosuppression in the progression of Mycobacterium tuberculosis pathogenesis.

The purpose of this Notice of Funding Opportunity (NOFO) is support applied research that will develop, advance, and apply mathematical models to investigate the utility and impact of prevention and control strategies for seasonal and pandemic influenza, including vaccination and treatment. This NOFO will establish a network of Influenza Modeling Centers that conducts research to facilitate the rapid development, harmonization, validation, synthesis, and communication of multiple mathematical models and their results for seasonal and pandemic influenza prevention and control. This NOFO is expected to generate advancements in the rapid sharing of validated modeling results from multiple models that will improve the evidence base for public health action and policy development.

The purpose of this funding opportunity is to stimulate research aimed at determining needs and best practices for the integration of palliative care into home and community settings. Home and community in this FOA refer to the place where an individual resides or lives. Home- and community-based palliative care programs ensure those with serious, advanced illness who do not require hospitalization but are not appropriate for hospice have access to high quality end-of-life and palliative care.

The goal of this initiative is to support research that can lead to the development of interventions for optimizing communication among patients, caregivers, and health care practitioners, and for preserving strong and supportive caregiving relationships throughout disease progression along the continuum of care for people with AD/ADRD. To these ends, basic research and translational research is solicited in two high-priority areas: (1) effective communications and relationships among patients, healthcare practitioners, and caregivers; and (2) associations between close relationship processes and health in caregiving relationships.

To that end, STTI is accepting applications for its 2019 Joan K. Stout, RN Research Grant, which is named in honor of Hugoton Foundation president Joan K. Stout, RN, FAAN, in recognition of her support of the role of simulation and technology by nurses incorporating evidence-based patient care. Through the program, grants of up to $5,000 will be awarded in support of ongoing evidence-based study by nurse researchers on the impact of the practice of nurse-led simulation in improving quality of care in clinical and/or academic settings with potential for further funding and ongoing research.

To that end, STTI is accepting applications for its 2019 Joan K. Stout, RN Research Grant, which is named in honor of Hugoton Foundation president Joan K. Stout, RN, FAAN, in recognition of her support of the role of simulation and technology by nurses incorporating evidence-based patient care. Through the program, grants of up to $5,000 will be awarded in support of ongoing evidence-based study by nurse researchers on the impact of the practice of nurse-led simulation in improving quality of care in clinical and/or academic settings with potential for further funding and ongoing research.

This Funding Opportunity Announcement (FOA) encourages applications that propose to complete planning, design, and preparation of the documentation necessary for implementation of investigator-initiated clinical trials. The trials should be hypothesis-driven, milestone-defined, related to the research mission of the NIAID and considered high-priority by the Institute. Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID (https://www.niaid.nih.gov/research/role).

The intent of the FY19 PRARP InCASA is to support innovative research that improves the quality of life and care for individuals living with the common symptoms of TBI and/or AD/ADRD and/or their families and care providers, as related to the PRARP's mission (see Section II.A, Program Description). The proposed work should innovatively challenge existing research paradigms or exhibit high levels of creativity within the contexts of the PRARP's mission and vision. This can include innovations and research for symptom reduction (e.g., cognitive, behavioral, function, mood), resiliency factors, increasing or maintaining independence, and support for families and care providers. The research innovations for the FY19 PRARP InCASA are expected to benefit the military, Veteran, and civilian communities. FY19 PRARP InCASA applications should be Innovation- and Impact-based.

Applications must articulate how results will lead to a clinical impact for Veterans with GWI even if a clinical impact is not an immediate outcome. All applications must focus on features of GWI and Veterans of the 1990-1991 Gulf War affected by GWI. It is the responsibility of the Principal Investigator (PI) to clearly and explicitly articulate the project's potential impact on GWI. The types of activities supported include, but are not limited to, expansion of limited data on candidate markers, mechanistic targets; therapeutics and interventions; validation and advanced research on druggable mechanistic targets, identification and development of leading compounds, and collection of preclinical data for repurposing an existing approved drug or for new Investigational New Drug (IND) application submissions to the U.S. Food and Drug Administration (FDA). Applicants proposing to test FDA-approved drugs in animal models for efficacy must explain why preclinical testing is required prior to clinical pilot trials in humans

The purpose of this Indian Health Service (IHS) cooperative agreement is to recruit, retain, graduate and increase the number of registered nurses, certified nurse midwives and nurse practitioners who deliver health care services to American Indian/Alaska Native (AI/AN) communities. The primary objectives of this cooperative agreement grant award are to: (1) recruit and train AI/AN individuals to be baccalaureate prepared nurses; (2) facilitate associate degree registered nurses becoming baccalaureate prepared registered nurses; (3) provide a program that prepares practicing registered nurses for advanced nursing education; (4) provide a program that encourages registered nurses and advanced practice nurses to provide or continue to provide, health care services to AI/AN communities; and (5) provide scholarships to AI/AN individuals that will cover tuition, books, fees, room and board, stipend for living expenses, or other expenses incurred in connection with baccalaureate level nursing or advanced practice nursing programs. This notice of funding opportunity solicits applications that provide a preference to AI/AN students and a curriculum with a rural health and public health focus.

USAID is seeking to enhance our malaria vaccine investments through a collaborative design process. The goal of USAID's Malaria Vaccine Development Program (MVDP) is to demonstrate the proof of concept of a vaccine to reduce morbidity and mortality due to malaria caused by infection with Plasmodium falciparum. Target malaria vaccine end characteristics will include at least 75% efficacy and evidence of affordability. USAID intends to support efforts towards vaccines that have the potential to directly protect recipients against disease caused by P. falciparum such as vaccines that target the pre-erythrocytic (sporozoite and liver stage) and erythrocytic stages of the life cycle. The purpose of this Addendum is to solicit Expressions of Interest (EOI) for novel and innovative approaches to malaria vaccine development that would encompass preclinical development through proof of principle clinical studies to motivate advanced development of a deployable, effective malaria vaccine.

This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH), invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications. United States SBCs that have the research capabilities and technological expertise to contribute to the R&D mission(s) of the NIH awarding components identified in this FOA are encouraged to submit STTR grant applications in response to identified topics (see PHS 2019-2 SBIR/STTR Program Descriptions and Research Topics for NIH.

To help advance this mission, ATS is accepting applications for the 2019 ATS Foundation Nursing Research Award. Through the program, a single grant of $8,000 will be awarded to a licensed, registered nurse with a PhD who is interested in pulmonary, critical care, and sleep medicine. ATS has a particular interest in proposals that have a high likelihood to advance the understanding of pulmonary, critical care, and sleep, with the goal of preventing these conditions and improving patient outcomes. Presentation by the researcher is expected at an ATS international conference within two years of the completion of his/her research.